Corrigendum: The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype (Front. Cardiovasc. Med., (2022), 9, 1022755, 10.3389/fcvm.2022.1022755)

MLA

Gavazzoni M., et al. Corrigendum: The Atrial Secondary Tricuspid Regurgitation Is Associated to More Favorable Outcome than the Ventricular Phenotype (Front. Cardiovasc. Med., (2022), 9, 1022755, 10.3389/Fcvm.2022.1022755). 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1383756535&authtype=sso&custid=ns315887.

APA

Gavazzoni M., Gavazzoni, M., Heilbron, F., Badano, L., Radu, N., Cascella, A., Tomaselli, M., Perelli, F., Caravita, S., Baratto, C., Parati, G., Muraru, D., Gavazzoni M., Heilbron F., Badano L., Radu N., Cascella A., Tomaselli M., Perelli F., … Muraru D. (2023). Corrigendum: The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype (Front. Cardiovasc. Med., (2022), 9, 1022755, 10.3389/fcvm.2022.1022755).

Chicago

Gavazzoni M., M Gavazzoni, F Heilbron, L Badano, N Radu, A Cascella, M Tomaselli, et al. 2023. “Corrigendum: The Atrial Secondary Tricuspid Regurgitation Is Associated to More Favorable Outcome than the Ventricular Phenotype (Front. Cardiovasc. Med., (2022), 9, 1022755, 10.3389/Fcvm.2022.1022755).” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1383756535&authtype=sso&custid=ns315887.